Similar Search Results

An empirical model of drug detailing : dynamic competition and policy implications

Liu, Qiang; Gupta, Sachin; Venkataraman, Sriram; Liu, Hongju - In: Management science : journal of the Institute for … 62 (2016) 8, pp. 2321-2340

Persistent link: https://www.econbiz.de/10011539516

Competition, regulation, and entry timing in marketing for pharmaceutical line extensions

Kina, Samuel H. - 2011

Persistent link: https://www.econbiz.de/10011949716

A ban on "private label" generic pharmaceuticals : legal and economic context

Anis, Aslam H.; Harvard, Stephanie - In: International journal of the economics of business 22 (2015) 2, pp. 219-229

Persistent link: https://www.econbiz.de/10011405945

Regulation and competition in the Taiwanese pharmaceutical market under national health insurance

Liu, Ya Ming; Yea-huei Kao Yang; Hsieh, Chee-Ruey - In: Journal of health economics 31 (2012) 3, pp. 471-483

Persistent link: https://www.econbiz.de/10009625666

An empirical model of drug pricing and competition : a dynamic perspective

Camejo, Rodrigo Refoios; McGrath, Clare; Rutten, F. F. H. - In: International journal of economics and business research 6 (2013) 2, pp. 173-193

Persistent link: https://www.econbiz.de/10010351165

Manufacturing and Regulatory Barriers to Generic Drug Competition : A Structural Model Approach

Wang, Yixin (Iris) - 2020

Understanding the drivers of market concentration in the generic pharmaceutical industry is essential to guaranteeing the availability of low-cost generics. In this paper, we develop a structural model to capture the multiple determinants governing manufacturers' entry decisions; in particular,...

Persistent link: https://www.econbiz.de/10012852626

Does Regulation Drive Out Competition in Pharmaceutical Markets?

Danzon, Patricia M.; Chao, Li-Wei - 2011

best weak in this industry. This paper tests the hypothesis that regulation of manufacturer prices and of retail pharmacy … markets (US, UK, Canada, Germany) but that regulation undermines generic competition in strict regulatory systems (France …, Italy, Japan). Regulation of retail pharmacy further constrains competition in France, Germany and Italy. Regulation thus …

Persistent link: https://www.econbiz.de/10014038394

The impact of the entry of biosimilars : evidence from Europe

Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017

Persistent link: https://www.econbiz.de/10011708133

The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry

Banerjee, Tannista; Siebert, Ralph - 2014

Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...

Persistent link: https://www.econbiz.de/10010229875

Reforming the Swedish pharmaceuticals market : consequences for costs per defined daily dose

Bergman, Mats A.; Granlund, David; Rudholm, Niklas - In: International journal of health economics and management 16 (2016) 3, pp. 201-214

Persistent link: https://www.econbiz.de/10011811445

1
2
3
4
5
6
7
8
9
10
Next
Last